May 9, 2019
Promethera doses patients with HepaStem testing drug for Liver Stem Cell Therapy in Late-Stage NASH
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Chronic Liver Disease
March 19, 2019
SFA Therapeutics Wins Second Key U.S. Patent For Treatment of Chronic Liver Diseases
Targets Liver Cancer JENKINTOWN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/HCC?src=hash" target="_blank"gt;#HCClt;/agt;–SFA Therapeutics today announced approval of the second key U.S. patent derived from…